With the founding of RESEARCH.EXCELLENCE. in 2013, Thomas Gleissner translated his decades of experience in medical and pharmaceutical market research into his own independent enterprise. As a trained social scientist with a strong background in both quantitative and qualitative empirical research and deep expertise in addressing the challenges of marketing and product development through tailored methodologies, Gleissner has established a successful practice based in Frankfurt.

RESEARCH.EXCELLENCE. combines established and innovative research strategies and tailors them to the specific problem context of the client. Central to this approach is extensive experience across virtually all major therapeutic areas and a wide range of professional stakeholder groups, including healthcare professionals, patients, and carers.

For qualitative enquiries, Gleissner employs a variety of creative and projective techniques to explore motivations, underlying attitudes, and behavioural patterns. Quantitative methods are then used to validate qualitative findings and generate statistical insights, allowing for a robust interpretation of relevance and impact.

The company relies on a broad network of experienced and highly skilled collaborators, enabling the successful execution of both national and international research projects. Rather than applying a fixed methodological toolkit, RESEARCH.EXCELLENCE. selects its methods based on the knowledge objectives at hand, ensuring that each project delivers meaningful and actionable results.

Thomas Gleissner invested €40,000 in business infrastructure and research software tailored to the MedTech and medical device sectors. This investment was financed through a loan from the Frankfurter Gründerfonds.